CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy

NCT06212154 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Hemolytic Anemia
CD19 CAR-T Cell Infusion

Interventions

BIOLOGICAL: ThisCART19A

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]